Use of biologics to treat IBD in U.S. adults may be suboptimal
(HealthDay)—Varied study design and methodology make it difficult to assess real-world trends in adherence and persistence in use of biologics among U.S. adults with inflammatory bowel disease (IBD), according to a review ...
Mar 29, 2019
0
1